Clinical trial
Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With…
NCT00132496 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00132496 |
|---|---|
| Title | Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole |
| Official title | Safety and Efficacy of Rabeprazole in the Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux Disease |
| Intervention type | Drug |
| Interventions | rabeprazole sodium |
| Enrollment | 111 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Aug 22, 2005 |
| Last update posted | Dec 3, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: